RBOT vs. MGRM, CV, CVRX, SGHT, TLSI, INGN, PROF, ELMD, RCEL, and LNSR
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Monogram Orthopaedics (MGRM), CapsoVision (CV), CVRx (CVRX), Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), Inogen (INGN), Profound Medical (PROF), Electromed (ELMD), Avita Medical (RCEL), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry.
Vicarious Surgical vs. Its Competitors
Vicarious Surgical (NYSE:RBOT) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.
Monogram Orthopaedics has higher revenue and earnings than Vicarious Surgical. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
Vicarious Surgical currently has a consensus price target of $8.50, indicating a potential downside of 15.84%. Monogram Orthopaedics has a consensus price target of $5.40, indicating a potential downside of 4.51%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, analysts plainly believe Monogram Orthopaedics is more favorable than Vicarious Surgical.
In the previous week, Monogram Orthopaedics had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 3 mentions for Monogram Orthopaedics and 1 mentions for Vicarious Surgical. Vicarious Surgical's average media sentiment score of 1.77 beat Monogram Orthopaedics' score of 0.17 indicating that Vicarious Surgical is being referred to more favorably in the media.
Monogram Orthopaedics' return on equity of -115.71% beat Vicarious Surgical's return on equity.
47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are held by institutional investors. 12.0% of Vicarious Surgical shares are held by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Vicarious Surgical has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.
Summary
Monogram Orthopaedics beats Vicarious Surgical on 10 of the 15 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vicarious Surgical Competitors List
Related Companies and Tools
This page (NYSE:RBOT) was last updated on 7/21/2025 by MarketBeat.com Staff
